NewsPronto

 
Men's Weekly

.

ACN Newswire

Read more press releases from ACN Newswire here

New Drug Application of Penpulimab Co-developed by Sino Biopharmaceutical and Akeso Accepted by the National Medical Products Administration

  • Written by ACN Newswire

image

HONG KONG, May 26, 2020 - (ACN Newswire) - Sino Biopharmaceutical Limited (HKEX: 1177), a leading, innovative R&D driven pharmaceutical conglomerate in the PRC, has announced that the new drug application of the anti PD-1 monoclonal antibody drug (generic name: Penpulimab; R&D code: AK105) jointly developed and commercialized with Akeso,...

Read more: New Drug Application of Penpulimab Co-developed by Sino Biopharmaceutical and Akeso Accepted by...